Can a Nurse-Led online tool help rheumatoid arthritis patients manage flares from home?
NCT ID NCT07525856
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test whether a nurse-led telehealth self-monitoring program is acceptable and practical for people with rheumatoid arthritis. 104 adults who recently had a flare or medication change will use a web platform to report symptoms monthly. A rheumatology nurse will review their reports and provide guidance. The study aims to see if this approach is convenient and helpful for patients and clinics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nurse-led telehealth remote self-monitoring via a web platform
What this could lead to
If successful, this approach could offer a convenient, nurse-supported way for rheumatoid arthritis patients to monitor their condition from home and get timely care.
What could go wrong
This is a small pilot study (104 participants) testing only acceptability and feasibility, not effectiveness. The results may not apply to all patients or clinics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Quebec-Universite Laval
Québec, Quebec, G1V4G2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre de l'ostéporose et de rhumatologie de Québec
Québec, Quebec, G1V 2M1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hopital Fleurimont et Hotel Dieu de Sherbrooke
Sherbrooke, Quebec, J1H 5H3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Hopital general de Montreal
Montreal, Quebec, H3H 1V6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact